search-icon
AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Intel’s breakup begins with sale of $8.75B-valued Altera to private equity giant Silver Lake
2
Deel CEO Alex Bouaziz surfaces in Dubai as Rippling struggles to serve lawsuit
3
Fintech Tapcheck raises $225M—$25M Series A extension and $200M facility—to expand real-time pay
4
Armis president sets bold goal: $1B in sales in three years, IPO in two
5
Deel CEO not served in Rippling lawsuit as whistleblower placed under 24/7 guard
More news Buzzmore

Synthon

1 stories about Synthon
מפעל חברת טבע הר חוצבים ירושלים

Teva's Blockbuster Drug Takes Another Generic Blow

26.10.17|Lilach Baumer
Mylan and European Partner Synthon won U.K. patent case related to Teva's Copaxone
ProfilesEngineServlet?at=39&mi=10&pt=18&dpi=1243103233&pai=cTech&dpn=4409&mt=1